Medefil, Inc. is a U.S.-based specialty pharmaceutical company focused on the development and manufacturing of sterile injectable drug products and prefilled syringes. Headquartered in Glendale Heights, Illinois, Medefil is known for its robust capabilities in aseptic filling, lyophilization, and terminal sterilization. The company is FDA-approved and operates under strict cGMP standards, supplying hospitals, clinics, and healthcare providers with critical therapies that emphasize safety, quality, and compliance.
A key offering from Medefil is its sterile diluent prefilled syringes, which support the growing market for lyophilized biologics and injectables requiring reconstitution. These
Medefil, Inc. is a U.S.-based specialty pharmaceutical company focused on the development and manufacturing of sterile injectable drug products and prefilled syringes. Headquartered in Glendale Heights, Illinois, Medefil is known for its robust capabilities in aseptic filling, lyophilization, and terminal sterilization. The company is FDA-approved and operates under strict cGMP standards, supplying hospitals, clinics, and healthcare providers with critical therapies that emphasize safety, quality, and compliance.
A key offering from Medefil is its sterile diluent prefilled syringes, which support the growing market for lyophilized biologics and injectables requiring reconstitution. These ready-to-use syringes, available in Sterile Water for Injection (USP) and 0.9% Sodium Chloride Injection (USP), help simplify the administration process, reduce dosing errors, and enhance patient safety. Available in 6 mL and 12 mL sizes with custom fill options from 1 mL to 10 mL, they offer a user-friendly solution for medical professionals and an opportunity for product differentiation.
Incorporated in 1998, Medefil initially focused on saline and heparin flush syringes, installing fully automated syringe lines that have produced over one billion sterile prefilled units to date. Building on this foundation, the company expanded into formulation and R&D, launching a state-of-the-art lab and additional manufacturing lines. Today, Medefil offers end-to-end injectable solutions with a commitment to innovation, operational excellence, and long-term partnerships across the pharmaceutical industry.
